Indication: Tukysa, a kinase inhibitor

Tuksya is a kinase inhibitor recommended in combination with Trastuzumab and Capecitabine for treating adult patients with advanced unresectable or metastatic HER2-positive breast cancer, including patients with brain metastases who received one or more prior anti-HER2-based regimens in the metastatic setting and in combination with Trastuzumab for the treatment of adult patients with RAS wild-type HER2-positive […]

Treatment Options for Metastatic Breast Cancer

Metastatic breast cancer (also called stage IV or advanced breast cancer) is not a specific type of breast cancer. Stage IV or metastatic breast cancer is known as the most leading stage of breast cancer. Stage IV breast cancer is breast cancer that has progressed beyond the breast and surrounding lymph nodes to other areas […]